| Trial ID: | L0953 |
| Source ID: | JPRN-UMIN000001071
|
| Associated Drug: |
Ezetimibe
|
| Title: |
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non-alcoholic fatty liver disease
|
| Interventions: |
The research dietitian instructed all subjects to reduce their caloric intake by 300 kcal per day. The subjects were randomly assigned to receive one of the regimens; in Group A, the patients will receive Ezetimibe at a dose of 10mg per day for 6 months.<
|
| Outcome Measures: |
changes of AST, ALT, Total cholesterol, and LDL-cholesterol at month 6 after the start of therapynan
|
| Sponsor/Collaborators: |
Osaka City University Graduate School of Medicine
|
| Gender: |
All
|
| Age: |
20years-oldNot applicable
|
| Phases: |
Not selected
|
| Enrollment: |
60
|
| Study Type: |
Interventional
|
| Study Designs: |
Parallel Randomized
|
| Start Date: |
30/06/2011
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
2 April 2019
|
| Locations: |
Japan
|
| URL: |
https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001300
|
